Daniela Starcevic (Icahn School of Medicine, The Mount Sinai Hospital, New York, NY USA) discusses her work with the Resilience Project and their development of a large Ion AmpliSeq™ Panel for targeted sequencing of hundreds of genes that cause rare disorders.
We wrote about the Resilience Project from the Mount Sinai Hospital here, and here is a press release making the announcement. Press Release
Revolutionizing Gene Editing with CRISPR and Digital PCR – A Conversation with Dr. Dustin Rubinstein
In a recent Absolute Gene-ius podcast episode titled “CRIS...
Read More
Harnessing Applied Biosystems™ TaqMan™ Real-Time PCR Assays for research in profiling miRNA and gene expression in cystic fibrosis
Cystic fibrosis (CF) is a severe inherited disease ch...
Read More
How the discovery of a mutation in a young Spanish girl with severe lupus is forging the path for new treatments
How the discovery of a mutation in a young Spanish girl with...
Read More
Studying Spinal Muscular Atrophy With Digital PCR
Advancing Nucleic Acid Quantification for SMA Research A Mul...
Read More
Leave a Reply